Twelve Points Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Twelve Points Wealth Management's ABBV Position: Q2 2026 in Review
Twelve Points Wealth Management reduced its AbbVie (ABBV) stake by 1.9% in Q2 2026, selling an estimated $20.7K and leaving 4,906 shares worth $1.23M. The position accounts for 0.25% of the portfolio, ranked #81.
Twelve Points Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.44M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Twelve Points Wealth Management held 4,906 shares of AbbVie worth $1.23M as of Q2 2026.
- Twelve Points Wealth Management sold 96 AbbVie shares in Q2 2026, an estimated $20.7K.
- AbbVie made up 0.25% of Twelve Points Wealth Management's portfolio in Q2 2026, its #81 holding.
- Twelve Points Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- Twelve Points Wealth Management's AbbVie position peaked at $1.44M in Q3 2025.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Twelve Points Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.